Pelthos Therapeutics Inc. (PTHS) stock news · rev $16.8M
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
This PTHS news page leads with what Pelthos Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for PTHS yet. We will not pad this page with generic market recap.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PTHS stock page; for the tape open the quote page.
PTHS stock news FAQ
What are PTHS's latest revenue and net income?
Latest cached Pelthos Therapeutics Inc. (PTHS) revenue for Dec 31, 2025 was $16.8M. Net income was -$43.3M. Statements: https://lician.com/financials/pths
What is PTHS's market cap?
Pelthos Therapeutics Inc. (PTHS) market cap is $94.7M on the latest cached fundamentals snapshot.
What kind of company is PTHS?
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Where is PTHS stock news listed?
Cached stock news for Pelthos Therapeutics Inc. (PTHS) is listed at https://lician.com/news/pths. Filings: https://lician.com/sec/pths
Not investment advice.